Virscio Publishes Data Validating Non-Human Primate Model for Testing Chronic Retinal Neovascularization and Vascular Leakage Drug Candidates Findings published in peer-reviewed Experimental Eye Research Establishment of NHP model meaningfully de-risks drug candidates for severe, prevalent retinal diseases responsible for vision loss NEW...

RxGen Rebrands as Virscio to Reflect Corporate Growth and Enhanced Focus on Comprehensive Suite of Preclinical Research Offerings and Capabilities NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- RxGen, a translational research company ensuring definitive, actionable preclinical outcomes through the use of predictive, validated disease...

RxGen to Present Alzheimer’s Disease APP/Abeta Cellular and Animal Models at the Society for Neuroscience’s 49th Annual Meeting NEW HAVEN, Conn., Oct. 14, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, will be presenting a poster highlighting its progress in advancing preclinical models of...

RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in...